Skip to content
September 12, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Genomics and Precision Medicine
  • Visionaries of the Genome: ASHG Announces 2026 Professional Award Recipients
  • Genomics and Precision Medicine

Visionaries of the Genome: ASHG Announces 2026 Professional Award Recipients

Evan Lee Salim September 12, 2026 7 minutes read
visionaries-of-the-genome-ashg-announces-2026-professional-award-recipients

ROCKVILLE, Md. — The American Society of Human Genetics (ASHG), the world’s preeminent professional organization for human genetics and genomics, officially announced its 2026 Professional Award recipients on Thursday, August 13, 2026. The seven honorees represent a cross-section of the brightest minds currently driving the field forward, ranging from legendary pioneers in population genetics to innovative educators reshaping how the next generation understands human biological diversity.

These prestigious awards recognize extraordinary achievements in research, leadership, mentorship, and public advocacy. The recipients will be formally honored during the upcoming ASHG 2026 Annual Meeting, scheduled for October 20–24 in Montréal, Canada—an event that serves as the premier global forum for geneticists to exchange breakthroughs and set the trajectory for the coming decade of genomic medicine.

A Legacy of Innovation: The 2026 Honorees

The ASHG awards reflect a commitment to celebrating not just scientific discovery, but the infrastructure, communication, and human support systems that make that discovery possible.

ASHG Announces Recipients of the 2026 Professional Awards

The Lifetime Achievement Award: Dr. Yusuke Nakamura

The society’s highest honor, the Lifetime Achievement Award, was bestowed upon Dr. Yusuke Nakamura, President of the National Institutes of Biomedical Innovation, Health and Nutrition in Japan. Dr. Nakamura’s career is a testament to the transformative power of sustained scientific inquiry.

His early work in the 1980s and 90s, particularly the development of Variable Number Tandem Repeat (VNTR) markers, provided the essential tools for the era of positional cloning. His research into the APC gene and colorectal cancer genetics fundamentally altered the landscape of modern molecular oncology. Beyond the bench, Dr. Nakamura was a key architect of the International HapMap Project and the visionary behind BioBank Japan, infrastructure that has become indispensable to modern precision medicine.

The Leadership Award: Dr. Aravinda Chakravarti

Dr. Aravinda Chakravarti, Director of the Center for Human Genetics and Genomics at NYU Grossman School of Medicine, received the Leadership Award. A former ASHG president, Dr. Chakravarti has spent his career bridging the gap between statistical genetics and clinical application. His foundational work on cystic fibrosis, Hirschsprung disease, and the influence of non-coding genetic variation has shaped current models of complex disease. As a pillar of the Human Genome Project and the 1000 Genomes Project, his influence on the field’s collaborative standards remains unparalleled.

ASHG Announces Recipients of the 2026 Professional Awards

The Scientific Achievement Award: Dr. Wendy Chung

Dr. Wendy Chung, Chief of Pediatrics at Boston Children’s Hospital, was recognized with the Scientific Achievement Award. Over the last decade, Dr. Chung has become a global leader in translating genomic research into direct patient care. Having identified over 60 novel disease genes, her work spans a vast spectrum of conditions, including neurodevelopmental disorders, metabolic disease, and rare Mendelian conditions. Her commitment to "patient-centered leadership" has ensured that the speed of laboratory discovery is matched by the speed of clinical implementation.

The Early Career Award: Dr. Rebecca Ahrens-Nicklas

The Early Career Award highlights investigators whose work promises to redefine the field. Dr. Rebecca Ahrens-Nicklas, of the Children’s Hospital of Philadelphia (CHOP), is at the forefront of this new era. Her pioneering role in delivering the world’s first personalized in vivo CRISPR therapy for an infant with an ultra-rare disease serves as a blueprint for the future of individualized genomic medicine.

The Advocacy Award: Roxanne Khamsi

Recognizing that the impact of science is limited by the public’s understanding, the ASHG Advocacy Award was presented to journalist Roxanne Khamsi. A contributing writer for The Atlantic, Khamsi has spent two decades demystifying complex genetic topics for the public. Her recent book, Beyond Inheritance, challenges reductive, deterministic views of genetic mutations, providing a vital bridge between rigorous scientific consensus and public discourse.

ASHG Announces Recipients of the 2026 Professional Awards

The Education Award: Dr. Robbee Wedow

Dr. Robbee Wedow of Purdue University received the Education Award for his efforts in developing the "Humane Genetics Curriculum" (HGC). In an era of increased sensitivity regarding ancestry and race, Dr. Wedow’s curriculum provides educators with a framework to teach genetics with scientific precision and social responsibility. His work ensures that the next generation of professionals in law, policy, and medicine can navigate the nuances of genetic data with care.

The Mentorship Award: Dr. Nancy B. Spinner

Finally, the Mentorship Award was presented to Dr. Nancy B. Spinner, Associate Chair of Genomic Strategy at Northwell Health. Over a 35-year tenure at the Children’s Hospital of Philadelphia and the University of Pennsylvania, Dr. Spinner has been a quiet force behind the success of countless researchers, having trained over 23 laboratory directors who are currently active in the field.

Chronology of Recognition

The selection process for these awards spans several months, beginning with a call for nominations from the global membership. The winners were chosen by an ASHG committee that evaluates candidates based on the impact, innovation, and long-term sustainability of their contributions.

ASHG Announces Recipients of the 2026 Professional Awards
  • August 13, 2026: Public announcement of the 2026 Professional Award recipients.
  • October 20–24, 2026: Formal award presentation ceremonies at the ASHG Annual Meeting in Montréal.
  • Fall/Winter 2026: Continued academic engagement as awardees deliver keynote addresses and participate in panel discussions at regional and international forums.

The State of the Field: Supporting Data and Context

The 2026 honorees represent a shift in the field of human genetics. While the early 2000s were defined by the massive, multi-national effort to sequence the human genome, the current decade is defined by "translation" and "interpretation."

Data provided by ASHG reflects this trend:

  • Clinical Integration: There has been a 40% increase in the number of genetic counselors and clinical geneticists integrated into primary care settings since 2020.
  • Rare Disease Breakthroughs: The number of genetic conditions with an associated therapeutic path—a specialty of awardees like Dr. Chung and Dr. Ahrens-Nicklas—has doubled in the last five years.
  • Educational Demand: The HGC curriculum, championed by Dr. Wedow, has been implemented in over 500 classrooms nationwide, signaling a high demand for ethics-integrated genetics education.

Official Responses from ASHG Leadership

Dr. Susan A. Slaugenhaupt, President of the ASHG, underscored the symbolic weight of this year’s list of winners.

ASHG Announces Recipients of the 2026 Professional Awards

"ASHG is honored to recognize this exceptional group of awardees, whose work demonstrates the many ways human genetics and genomics can advance science and serve society," Dr. Slaugenhaupt stated during the announcement. "Each honoree has helped shape a stronger, more collaborative, and more impactful field. Their achievements inspire our community and reflect the promise of genetics to improve lives around the world. We are not just celebrating milestones; we are celebrating the architects of a healthier future."

Implications for the Future of Genomics

The recognition of these seven individuals highlights a crucial transition in the life sciences. By honoring individuals who focus on advocacy, education, and mentorship alongside those who focus on fundamental gene discovery, the ASHG is signaling that the future of the field depends as much on social integration as it does on technical prowess.

The implications for the medical community are clear:

ASHG Announces Recipients of the 2026 Professional Awards
  1. Precision Medicine at Scale: The work of Dr. Nakamura and Dr. Ahrens-Nicklas proves that personalized, CRISPR-based therapies are no longer theoretical—they are becoming the standard of care for ultra-rare conditions.
  2. Addressing Bias: Through the work of Dr. Wedow and Roxanne Khamsi, the scientific community is taking proactive steps to address historical biases and reductive thinking in genetics, ensuring that public engagement is rooted in accuracy.
  3. Sustainability of Talent: By honoring mentors like Dr. Spinner, the ASHG is highlighting the necessity of cultivating the next generation of diverse, ethically grounded researchers.

As the community prepares for the Montréal gathering in October, the focus will likely remain on how to sustain this momentum. With press registration now open, the global scientific community is watching to see how these leaders will frame the challenges and opportunities of the next five years. The 2026 awards are not merely a reflection of the past; they are a roadmap for the future of genomic medicine.

About the Author

Evan Lee Salim

Author

View All Posts

Post navigation

Previous: Bridging the Gap: AbbVie’s Maviret and the Complex Reality of Hepatitis C Eradication
Next: The Precision Revolution: How the Broad Institute is Rewriting the Future of Medicine

Related Stories

from-seedling-to-science-fair-superstar-how-a-rehobeth-high-students-peanut-became-a-genetic-icon
  • Genomics and Precision Medicine

From Seedling to Science Fair Superstar: How a Rehobeth High Student’s Peanut Became a Genetic Icon

Rifan Muazin September 12, 2026
the-precision-revolution-how-the-broad-institute-is-rewriting-the-future-of-medicine
  • Genomics and Precision Medicine

The Precision Revolution: How the Broad Institute is Rewriting the Future of Medicine

Suro Senen September 12, 2026
from-soil-to-sustainable-synthesis-the-genetic-revolution-in-perennial-grasses
  • Genomics and Precision Medicine

From Soil to Sustainable Synthesis: The Genetic Revolution in Perennial Grasses

Nila Kartika Wati September 11, 2026

Recent Posts

  • The Price of Administration: Deconstructing the Economics of Private Health Insurance
  • Unmasking a Master Regulator: Decades-Old Protein Reveals Surprising Role in Cancer Immunity, Offers New Therapeutic Hope
  • From Seedling to Science Fair Superstar: How a Rehobeth High Student’s Peanut Became a Genetic Icon
  • The Psychedelic Frontier: Definium Therapeutics Navigates the Commercial and Clinical Realities of LSD Therapy
  • Beyond Aesthetics: The Emerging Role of Botox in Transforming Scar Recovery

Recent Comments

No comments to show.

Archives

  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

the-price-of-administration-deconstructing-the-economics-of-private-health-insurance
  • Breast Cancer Legislation and Policy

The Price of Administration: Deconstructing the Economics of Private Health Insurance

Reynand Wu September 12, 2026
unmasking-a-master-regulator-decades-old-protein-reveals-surprising-role-in-cancer-immunity-offers-new-therapeutic-hope
  • Medical Research and Clinical Trials

Unmasking a Master Regulator: Decades-Old Protein Reveals Surprising Role in Cancer Immunity, Offers New Therapeutic Hope

Dwi Wanna September 12, 2026
from-seedling-to-science-fair-superstar-how-a-rehobeth-high-students-peanut-became-a-genetic-icon
  • Genomics and Precision Medicine

From Seedling to Science Fair Superstar: How a Rehobeth High Student’s Peanut Became a Genetic Icon

Rifan Muazin September 12, 2026
the-psychedelic-frontier-definium-therapeutics-navigates-the-commercial-and-clinical-realities-of-lsd-therapy
  • Treatment Innovations

The Psychedelic Frontier: Definium Therapeutics Navigates the Commercial and Clinical Realities of LSD Therapy

Evan Lee Salim September 12, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.